Pharmerica (PMC) Reports In-Line Q2 EPS

Pharmerica (NYSE: PMC) reported Q2 EPS of $0.47, in-line with the analyst estimate of $0.47. Revenue for the quarter came in at $519.6 million versus the consensus estimate of $508.31 million.Pharmerica reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• Sharon AI surges premarket; New Oriental gains, Medline slips